ONTX Onconova Therapeutics Inc

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.

$1.02
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
07/25/2013
206,694,391
91,962,438
$193,651,975
0.00%
SEC Edgar Online
10-Q
10-K
68232V405
US68232V4059
BD9MK29

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-7.91
14.20
949.27
-200.37%
-11,997.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy